[1]
C. BHAVANI and P. BALAJI, “QUALITY BY DESIGN AND CHARACTERIZATION OF EDARAVONE SLN TO IMPROVE BRAIN DELIVERY BY NASAL ROUTE FOR THE TREATMENT OF ALZHEIMER’S DISEASE”, Int J App Pharm, vol. 18, no. 1, Nov. 2025.